Literature DB >> 8912471

The role of the cell cycle in genitourinary carcinoma.

T W McGarvey1, S B Malkowicz.   

Abstract

The understanding of the cell cycle and the control of cellular proliferation has increased dramatically over the past years. Cancer is most likely caused by multiple genetic aberrations, therefore it seems likely that one or more genes involved in tumorigenesis will regulate a portion of the cell cycle. Cell cycle related genes, such as p53 are becoming important in determining prognosis. In addition, gene replacement therapy for a deleted gene may hold promise in treating malignancies. Further understanding of cell proliferation should bring marked improvements in the diagnosis and treatment of genitourinary malignancies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912471     DOI: 10.1007/bf00184603

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  98 in total

1.  Amplification at chromosome 11q13 in transitional cell tumours of the bladder.

Authors:  A J Proctor; L M Coombs; J P Cairns; M A Knowles
Journal:  Oncogene       Date:  1991-05       Impact factor: 9.867

2.  p16 gene in uncultured tumours.

Authors:  C H Spruck; M Gonzalez-Zulueta; A Shibata; A R Simoneau; M F Lin; F Gonzales; Y C Tsai; P A Jones
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

Review 3.  Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

4.  Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.

Authors:  M Hall; S Bates; G Peters
Journal:  Oncogene       Date:  1995-10-19       Impact factor: 9.867

5.  Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.

Authors:  Y Sonoda; T Yoshimoto; T Sekiya
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

6.  Human epithelial ovarian cancer allelotype.

Authors:  W Cliby; S Ritland; L Hartmann; M Dodson; K C Halling; G Keeney; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

7.  CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

Authors:  S Bates; L Bonetta; D MacAllan; D Parry; A Holder; C Dickson; G Peters
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

8.  Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.

Authors:  Z A Khatib; H Matsushime; M Valentine; D N Shapiro; C J Sherr; A T Look
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

9.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

10.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.

Authors:  S B Parker; G Eichele; P Zhang; A Rawls; A T Sands; A Bradley; E N Olson; J W Harper; S J Elledge
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

View more
  2 in total

1.  Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.

Authors:  M Kuczyk; S Machtens; K Hradil; J Schubach; W Christian; R Knüchel; J Hartmann; C Bokemeyer; U Jonas; J Serth
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

Review 2.  Regulating tumor suppressor genes: post-translational modifications.

Authors:  Ling Chen; Shuang Liu; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2020-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.